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Regulation of endonuclease activity by proteolysis prevents
breakage of unmodified bacterial chromosomes by type I
restriction enzymes
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ABSTRACT ClpXP-dependent proteolysis has been im-
plicated in the delayed detection of restriction activity after
the acquisition of the genes (hsdR, hsdM, and hsdS) that specify
EcoKI and EcoAI, representatives of two families of type I
restriction and modification (R-M) systems. Modification,
once established, has been assumed to provide adequate
protection against a resident restriction system. However,
unmodified targets may be generated in the DNA of an hsd1
bacterium as the result of replication errors or recombination-
dependent repair. We show that ClpXP-dependent regulation
of the endonuclease activity enables bacteria that acquire
unmodified chromosomal target sequences to survive. In such
bacteria, HsdR, the polypeptide of the R-M complex essential
for restriction but not modification, is degraded in the pres-
ence of ClpXP. A mutation that blocks only the modification
activity of EcoKI, leaving the cell with ’600 unmodified
targets, is not lethal provided that ClpXP is present. Our data
support a model in which the HsdR component of a type I
restriction endonuclease becomes a substrate for proteolysis
after the endonuclease has bound to unmodified target se-
quences, but before completion of the pathway that would
result in DNA breakage.
Within a bacterium that has a classical restriction and modi-
fication (R-M) system, the nucleotide sequences that define
the targets for attack by the resident restriction endonuclease
are concealed by the modification of appropriate bases within
them. For some systems this modification is achieved by the
methylation of specific adenine residues, and for others it is
achieved by methylation of cytosine residues. The restriction
endonuclease has the potential to attack DNA from different
strains of the same species because foreign DNA generally
lacks the protective imprint of the relevant methyltransferase
(for reviews see refs. 1 and 2). Restriction of the host cell’s
newly synthesized DNA normally is avoided, because the
unmethylated strand of each target sequence produced by
DNA replication is methylated before the next round of
replication. If, however, resident DNA were to acquire un-
modified target sequences, would it, like foreign DNA, become
a substrate for restriction? In this paper we show that in
situations where the modification of the host DNA by a type
I R-M system fails, an alternative level of protection impairs
the endonuclease activity of the restriction system and the
bacteria survive.
A type I R-M system is encoded by three genes: hsdR, hsdM,
and hsdS. The three polypeptides, HsdR, HsdM, and HsdS,
often designated R, M, and S, assemble to give an enzyme
(R2M2S1) that modifies hemimethylated DNA and restricts
unmethylated DNA. A smaller complex (M2S1) has only the
methyltransferase activity. The S subunit confers target spec-
ificity; hence, both complexes and both activities respond to
the same nucleotide sequence.
Type I systems of enteric bacteria have been divided into
discrete families by tests for cross-hybridization between genes
and cross-reactivity with antibodies raised against the arche-
typal member of each family (3–5). Four families of distantly
related systems have been identified (types IA, IB, IC, and ID),
and where complementation tests have been done they indi-
cate that enzymes in the same family can interchange subunits,
but those from different families cannot (6, 7).
No transcriptional regulation of type I R-M genes has been
detected; yet these genes are transferred readily to recipient
bacteria devoid of the relevant modification activity (8–10). It
is presumed that the cells survive the acquisition of the new
R-M system because they become restriction proficient only
after the modification activity is established. Experiments in
support of this identify a lag of ’15 generations before the cells
become restriction-proficient after the acquisition of hsd genes
by conjugation (11). The ClpXP protease was shown to be
essential for the effective acquisition of genes specifying type
IA and IB systems, and for this reason proteolysis has been
implicated in the delayed expression of restriction activity (10).
The acquisition of a new specificity system is not the only
situation in which a temporary loss of restriction proficiency
has been detected. A well documented example, referred to as
restriction alleviation (RA), occurs in response to treatments
that damage DNA (12–14). UV light, nalidixic acid, and
2-aminopurine (2-AP) have been shown to induce restriction
alleviation. It is possible that the temporary loss of restriction
proficiency associated with the establishment of a new speci-
ficity is an example of RA. If this is so, ClpXP would be
required for the alleviation of restriction in response to DNA
damage. We have tested this hypothesis and show ClpXP to be
a common requirement for RA in response to the various
agents that damage DNA. This led us to identify steps in the
molecular pathway that protect bacteria against the potentially
lethal effects of restriction after DNA damage in a cell with a
resident type I system or after the acquisition of a type I system
capable of attacking the resident DNA.
MATERIALS AND METHODS
Bacterial Strains, Phages, Plasmids, and General Micro-
bial Methods. Bacterial strains are listed in Table 1. Inte-
gration-deficient, lhsdcI857 phages were used to transfer
hsd alleles to bacterial chromosomes: lNM1367 includes
hsdDRM(F269G)S1; lNM1376, hsdM1S1; lNM1394,
hsdM(F269G)S1; and lNM1384, hsdR(A619V) (17). JC9935
was used as the donor of the following derivatives of F9101:
F9101–102, hsdKR2M1S1 (11); F9101–301, hsdK
2 hsdA
1 (10);
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and F9101–103, zjj::Tn10 hsdKR1D(MS)5. F9101–103 was
selected after plasmid–chromosome allele exchange, as de-
scribed for F9101–301 (10). pNK3 was made by transferring
the HindIII-SmaI fragment containing hsdR from pBg3 (22)
to pACYC184 (23) digested with HindIII and NruI. Media
and general methods were as described previously (10).
Restriction Alleviation. 2-AP (400 mgyml) was added to
midlogarithmic cultures grown at 37°C in LB medium. Inten-
sive aeration was provided before and during the treatment.
After 1 h, the cells were washed, resuspended in fresh broth,
and tested for restriction. UV-induced RA was measured as
described in ref. 24, and RA in response to nalidixic acid was
measured as described by (13).
Analysis of Proteins. Polypeptides were separated by elec-
trophoresis through SDSypolyacrylamide gels (25). Western
blots used rabbit antisera against EcoKI or EcoAI and the
chemiluminescence detection system (POD) of Boehringer
Mannheim.
The stability of proteins was monitored after pulse-labeling
with [35S]methionine. Bacteria were grown at 37°C with in-
tensive aeration to an OD600 of 0.2–0.3 in minimal medium
supplemented with thiamin and all amino acids except methi-
onine and cysteine. Chloramphenicol (20 mgyml) maintained
the presence of pNK3. Each culture was divided, and 2-AP
(400 mgyml) was added to one aliquot. After 1.5 h, a 1-min
pulse of [35S]methionine (25 mCiyml) was given. Labeling was
stopped by diluting each culture with an equal volume of
prewarmed LB supplemented with L-methionine (15 mM) or
with L-methionine and 2-AP (400 mgyml). Intensive aeration
was maintained, and samples were taken at appropriate inter-
vals. Bacteria were collected by centrifugation, resuspended in
SDS sample buffer, and boiled for 5 min, and samples were
applied to SDSypolyacrylamide gels for the separation of
polypeptides by electrophoresis.
RESULTS
ClpXP Is Necessary for RA. A simple quantitative test for
restriction relies on the fact that most unmodified l phages are
killed when they infect Escherichia coli K-12; the phage
genome is a substrate for EcoKI, the resident restriction
system. The titer of an unmodified phage lysate (l.0) on a
restricting host relative to that on a nonrestricting derivative is
referred to as the efficiency of plating (EOP). Therefore, the
inverse of EOP quantifies restriction. RA is detected as a
temporary reduction in restriction (hence, an increased EOP)
after treatment of genetically restriction-proficient cells with
agents that damage DNA.
We examined RA for Clp1 and Clp2 strains in response to
each of three treatments; UV light, nalidixic acid, and 2-AP.
For each treatment, ClpX was essential for efficient RA (Fig.
1). A clpP strain was tested for RA in response to 2-AP, and
it also was deficient in RA (data not shown). The results
support our hypothesis that RA, in response to agents that
damage DNA, and the delayed expression of restriction activ-
ity after the acquisition of hsd1 genes by an hsd2 recipient are
both the outcome of a common ClpXP-dependent process. RA
for the EcoAI system in response to 2-AP also was shown to
be dependent on ClpX (data not shown).
‘‘Constitutive’’ RA. Restriction is alleviated in dam strains
(26). It is known that the Dam-methylase identifies the pa-
rental DNA strand during mismatch repair, and in dam
mutants mismatch repair leads to double-strand breaks
(DSBs) (27). This alleviation of restriction in dam strains led
us to question whether other mutations that impair the effi-
ciency or fidelity of DNA replication might induce RA. If such
a phenotype occurred, would it be dependent on ClpXP? We
tested topA, mutD, and dam strains.
Mutants deficient in topoisomerase I, like wild-type cells
treated with nalidixic acid, have problems in DNA replication;
DSBs may occur when the replication forks stall (28). In
Table 1. E. coli K-12 strains
Strain Relevant genotype Source or origin
C600 hsdK
1 See ref. 10
5K hsdR514 See ref. 10
CB51 dam-3 C. Boyd
JC9935 recA13 See ref. 10
LE451 rac-0 recA srl::Tn10 Ref. 15
NM477 D(hsdMS)5 See ref. 10
NM659 DrecA::cat This laboratory
NM679 D(hsdRMS) Ref. 16
NM799 hsdR(A619V) Refs. 17 and 18
NM802 DhsdR4 This laboratory
SG22007 DclpP::cat Ref. 19
SG22080 DclpX::kan Ref. 20
SG22129 DclpP::cat D clpX::kan S. Gottesman
RH6972 dnaQ::miniTn10 (mutD) D. R. F. Leach
RS2 topA10 Ref. 21
TPC48 zjj::Tn10 dnaCts See ref. 10
NK31 gyrA96 Ref. 10
NK167 hsdK
2hsdA
1 Ref. 10
NK300 rac-0 recA1srl1 LB451 3 P1(C600)
NK301 rac-0 gyrA96 NK300 3 P1(NK31)
NK302 dam NK301 3 P1(CB51)
NK303 DclpP NK301 3 P1(SG22007)
NK304 DclpX NK301 3 P1(SG22080)
NK308 DrecA NK301 3 P1(NM659)
NK309 zjj::Tn10 dnaCts NK301 3 P1(TPC48)
NK310 hsdR NK301 3 P1(5K)
NK311 D(hsdRMS) NK309 3 P1(NM679)
NK312 D(hsdRMS) DclpX NK311 3 P1(SG22080)
NK315 dam DclpX NK302 3 P1(SG22080)
NK320 DclpX NK300 3 P1(SG22080)
NK323 DclpX DrecA NK304 3 P1(NM659)
NK324 D(hsdRMS) DclpX DrecA NK312 3 P1(NM659)
NK325 hsdR DclpX NK310 3 P1(SG22080)
NK326 mutD NK301 3 P1(RH6972)
NK327 mutD DclpX NK326 3 P1(SG22080)
NK329 topA10 DclpP DclpX RS2 3 P1(SG22129)
NK351 hsdR(A619V) NK309 3 P1(NM799)
NK352 D(hsdMS)5 NK309 3 P1(NM477)
NK354 hsdK
2hsdA
1 NK309 3 P1(NK167)
NK355 hsdK
2hsdA
1 DclpX NK354 3 P1(SG22080)
NK378 DhsdR hsdM(F269G) NM802 3 lNM1367
NK379 DhsdR NK309 3 P1(NM802)
NK380 DhsdR DclpX NK379 3 P1(SG22080)
NK382 DhsdR hsdM(F269G) NK309 3 P1(NK378)
NK383 DhsdR hsdM(F269G) DrecA NK382 3 P1(NM659)
NK384 DhsdR hsdM(F269G) DclpX NK382 3 P1(SG22080)
NK386 hsdM(F269G) NK301 3 lNM1394
NK388 hsdR(A619V)hsdM(F269G) NK386 3 lNM1384
Affiliations: C. Boyd, Medical Research Council, Human Genetics
Unit, University of Edinburgh; S. Gottesman, National Cancer Insti-
tute, Bethesda, MD; D. R. F. Leach, Institute of Cell and Molecular
Biology, University of Edinburgh.
FIG. 1. Restriction of unmodified phage l by clp1 (NK301, NK300
for nalidixic acid) and clpX (NK304, NK320 for nalidixic acid)
bacteria. Only clp1 cells show restriction alleviation.
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contrast, a mutD mutation enhances the error rate of DNA
polymerase III (29) and the increased frequency of mismatches
may mimic the effect of 2-AP, an analogue of adenine that
causes base pair transitions.
Restriction by dam, topA, or mutD strains was at least
100-fold less efficient than restriction by wild-type E. coli K-12
(Fig. 2). If this poor restriction is the result of constitutive
expression of RA activated in response to either DNA damage
or mismatches, then a mutation in clpX or clpP should restore
restriction. Consistent with this prediction, the efficiency of
restriction was enhanced by approximately 100-fold in the
absence of ClpXP protease (Fig. 2).
ClpXP-Deficient, Restriction-Proficient Bacteria Die Dur-
ing Prolonged Exposure to 2-AP. After prolonged treatment
with 2-AP (3–4 h at 400 mgyml), clp2 (NK303 and NK304) but
not clp1 (NK301) bacteria become filamentous, a phenotype
characteristic of the SOS response. 2-AP does not normally
activate the SOS response but, in the absence of ClpXP, it
could induce a chain of events that leads to DNA damage. The
relevance of a RecA-dependent repair pathway is supported by
the observation that recA clpX double mutants (NK323) are
supersensitive to 2-AP and do not survive low concentrations
(40 mgyml) of 2-AP in the medium. In contrast, a recA clp1
hsd1 strain (NK308) is no more sensitive to 2-AP than its rec1
counterpart (NK301); recA strains resemble rec1 in their RA
response to 2-AP.
Is ClpXP needed in the presence of 2-AP to prevent DNA
damage by the resident restriction endonuclease? We made
the clpX bacteria deficient in restriction both by deleting the
hsd genes (NK312) and by including a mutation in hsdR
(NK325), the gene essential for restriction. The restriction-
deficient bacteria were not sensitive to 2-AP. Similarly, the
hypersensitivity of the recA clpX strain was relieved by inac-
tivation of the endonuclease activity. We suggest that during
prolonged treatment with 2-AP, the ClpXP-dependent path-
way is essential to prevent EcoKI from causing DNA damage
and consequent cell death.
RA Induced by 2-AP Is Associated with a Deficiency of
HsdR. RA is not correlated with a loss of modification activity
(14, 30). It could, therefore, be the result of a deficiency in
HsdR and the consequent depletion of EcoKI (R2M2S1), but
not the modification enzyme (M2S1).
The HsdR and HsdM subunits were monitored by Western
blots after the addition of 2-AP to both clp1 and clpX bacteria
(Fig. 3). After a lag of 20 min, a reduction in the concentration
of HsdR, but not HsdM, was detected. This deficiency of HsdR
was found only in clp1 cells in response to 2-AP. RA, there-
fore, correlated with a ClpX-dependent reduction in the
concentration of HsdR, the polypeptide essential for restric-
tion, but not modification.
HsdR Is Degraded in clp1 Cells Treated with 2-AP. The very
low concentration of HsdR detected in Clp1 cells after a
period of growth in the presence of 2-AP (Fig. 3) is consistent
with the degradation of HsdR in the presence of ClpXP, but
it could be argued that ClpXP in some way affects the synthesis
rather than the degradation of HsdR.
We therefore assayed the stability of HsdR in clp1 and clpX
cells in response to treatment with 2-AP. The preferred
experiment was to rely on the chromosomal hsdR gene, but the
signal generated from a single copy of hsdR was weak com-
pared with those generated by other proteins. Gene dosage was
increased by cloning hsdR in pACYC184, a low-copy-number
vector. clp1 hsd1 (NK301) and clpX hsd1 (NK304) bacteria
transformed with the hsdR1 plasmid (pNK3) were treated with
2-AP for 90 min to allow the establishment of RA before they
were pulse-labeled with [35S]methionine. HsdR was unstable
in Clp1 but not ClpX2 cells after 2-AP treatment (Fig. 4). In
the absence of 2-AP (data not shown) the HsdR polypeptide
was stable in clp1 and clpX cells for at least 180 min.
These results are consistent with 2-AP as the activator of a
RA pathway in which HsdR is susceptible to ClpXP-dependent
proteolysis.
Functional EcoKI Is Obligatory for the Loss of HsdR That
Is Characteristic of RA. Is active EcoKI necessary to generate
the signal that leads to ClpXP-dependent degradation of
HsdR? To answer this question we tested whether 2-AP-
induced depletion of HsdR occurs in restriction-deficient
mutants. One of the mutants tested has a missense mutation
in hsdR (NK351), and the other (NK352) has a wild-type hsdR
gene, but hsdM and hsdS are deleted so that HsdR cannot form
an EcoKI complex.
HsdR was not depleted in either mutant in response to 2-AP
(Fig. 5a). This finding implies that a functional endonuclease
is required for induction of the pathway that leads to degra-
dation of HsdR. If the products of restriction by a type I
enzyme are the stimulus for RA, the endonuclease activity of
one R-M system should induce RA for a different system. We
tested whether a functional type IB system (EcoAI), for which
RA is regulated in a ClpXP-dependent manner, induced
degradation of the HsdR polypeptide of the inactive type IA
system, EcoKI.
We transferred F9hsdAR1M1S1 (F9101–301) to the three
strains used in the previous experiment (Fig. 5a):
hsdKR1M1S1, hsdKR2M1S1, and hsdKR1D(MS). The
transconjugants, both untreated and treated with 2-AP, were
FIG. 2. Restriction of unmodified phage l by dam (NK302), mutD
(NK326), and topA (RS2) strains and their clpX derivatives (NK315,
NK327, and NK329). It is known that topA strains accumulate
compensatory mutations in gyrA or gyrB (21), but the topA10 strain
(RS2) is not known to have a compensatory mutation (21), and the
topA mutation itself correlates with impaired restriction (G. P. Davies,
personal communication).
FIG. 3. Assays for HsdR and HsdM polypeptides after treatment
with 2-AP. (a) clp1 bacteria (NK301). (b) clpX bacteria (NK304). In
the absence of 2-AP (data not shown), the assays for clp1 and clpX
bacteria were indistinguishable from those seen in b. EcoKI polyclonal
antibody, used in these Western blots, fails to detect HsdS, but detects
HsdR and HsdM and some other E. coli proteins.
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assayed for EcoAI- and EcoKI-dependent restriction in vivo
and for the presence of HsdR polypeptides. 2-AP caused RA
of functional R-M systems, and HsdR from any restriction-
proficient complex was lost (Fig. 5b). However, for the non-
functional EcoKI complex, RK remains even in the presence of
functional EcoAI. These data require that the stimulus for RA
is family-specific and therefore is not simply the product of
restriction.
Mutations Predicted to Confer a Restriction-Proficient,
Modification-Deficient (r1m2) Phenotype Cause Restriction
Alleviation. It is logical to expect that a mutation conferring an
r1m2 phenotype would be lethal. We chose to investigate a
mutation in hsdM (F269G) that abolishes methyltransferase
activity but has no effect on the binding of the cofactor
S-adenosylmethionine and therefore is predicted to leave a
functional endonuclease (31). This hsdM mutation was trans-
ferred from a lhsd phage (lNM1367) to the chromosome of
an hsdR strain. The presence of hsdM(F269G) (NK378) was
associated with the anticipated m2 phenotype. We tested the
naive prediction that the acquisition of an F9 with a functional
hsdR gene would generate r1m2 transconjugants and these
would die. However, we found no difference between the
survival of the recipients upon acquisition of F9hsdR1 and the
survival of recipients receiving the control F9 lacking an hsdR1
FIG. 5. Hsd subunits were monitored, after treatment with 2-AP,
using antibodies raised against the relevant R-M complex. HsdR is
degraded only when it is a part of a functional complex. (a) Degra-
dation of HsdR is prevented by a missense mutation in hsdR (track 5)
or by the absence of HsdM and S (track 8). (b) The presence of
functional EcoAI has no effect on the degradation of the HsdR subunit
of EcoKI (Upper), even though the HsdR subunit of EcoAI itself is
degraded (Lower, lanes 2, 5, and 8). The control tracks for EcoAI
contain a mixture of polypeptides in which HsdM and HsdS are present
in molar excess to give strong signals with antibody.
FIG. 6. The survival of hsdR1M2(F269G)S1 cells was assessed
after the conjugative transfer of hsdR1 to hsdR2M2S1 recipients. (a)
The experiment using F9101–103 (hsdR1). (b) The control experiment
with F9101–102 (hsdM1S1). Data are plotted for the following recip-
ients: NK379, hsdR (); NK380, hsdR clpX (); NK382, hsdRM (h);
NK384, hsdRM clpX ( n ); and NK383, hsdRM recA (F). The data show
that hsdR1M2(F269G)S1 cells survive only if the recipient is ClpX1.
FIG. 4. The stability of HsdR in vivo after treatment with 2-AP. Labeled polypeptides separated by electrophoresis through SDS-polyacrylamide
gels (6%) were detected by autoradiography. An extract from a strain lacking HsdR (NK311ypACYC184) was analyzed in the first track. Samples
from clp1 and clpX bacteria containing pNK3 were taken at the time intervals indicated after pulse labeling.
9760 Genetics: Makovets et al. Proc. Natl. Acad. Sci. USA 96 (1999)
allele (Fig. 6). We extended our experiment to include a recA
recipient in which DSBs would not be repaired; transfer of the
hsdR1 allele still occurred efficiently (Fig. 6).
The EOP of l.0 on the hsdR2M2S1 (F9hsdR1) transconju-
gants was 1021 in contrast to 5 3 1024 when the F9hsdR1 was
transferred to an hsdR2M1S1 recipient (the EOP of l.K was
1 in both cases). The low level of restriction by the m2
transconjugants is consistent with induction of the RA re-
sponse. Therefore, the conjugation experiments were ex-
tended to include clpX recipients. In the absence of ClpX,
transfer of the F9hsdR1 to the hsdR2M2S1 recipient was
lethal, consistent with the presence of functional restriction
endonuclease (Fig. 6). Our hypothesis predicts that the
transconjugant bacteria can survive in the presence of ClpXP
because of the activation of the RA pathway. If this suggestion
is correct, hsdR1M2S1 bacteria would be deficient in HsdR.
We chose to use chromosomal genes in preference to a
plasmid-borne hsdR to test this prediction. We transferred the
hsdM(F269G) mutation to the chromosome of NK301, an hsd1
strain. The hsdM recombinants were recognized by their m2
phenotype and could not be transduced to give clpX derivatives
(data not shown). These derivatives restricted l.0 with an effi-
ciency indicative of RA (EOP 5 1021). Consistent with the
induction of RA, HsdR was missing in the hsdM(F269G) strain
that encodes a functional restriction enzyme and present in a
derivative with a missense mutation in hsdR (Fig. 7). Importantly,
when hsdM(F269G) was replaced with the wild-type allele (see
legend to Fig. 7), HsdR was restored. Therefore, the loss of HsdR
is a consequence of the hsdM mutation. Our experiments with the
modification-deficient mutant show that E. coli has an extraor-
dinary capacity to protect itself against potential DNA damage
elicited by a resident type I R-M system.
DISCUSSION
The diagnostic feature of RA is an r2 phenotype despite a
restriction-proficient genotype (hsd1). The r2 phenotype that
persists for many generations in a transconjugant after the
acquisition of functional hsd genes by an hsd2 recipient (11, 32)
may be viewed as an example of RA. In this case, the establish-
ment of hsd1 genes in a naive bacterium depends on the ClpXP
protease (10). We now have shown that RA in response to a
variety of stimuli, including external agents and mutations that
affect the fidelity of DNA replication, also requires ClpXP. In two
quite different situations the presence of subunits of EcoKI was
monitored after the induction of RA. In the first, the bacteria
were treated with 2-AP, and in the second, a mutation in hsdM
(F269G) was introduced that blocks only the methyltransferase
activity of EcoKI (31). In both these examples of ClpXP-
dependent RA, a negligible level of HsdR remained. We propose
a general pathway for RA in which ClpXP is necessary for the
degradation of HsdR and the consequent r2 phenotype. Accord-
ing to this scheme, unmodified chromosomal DNA targets would
be a signal for the cell to protect its own DNA from restriction.
We believe that all the stimuli for RA examined by us rely on the
presence of unmodified target sequences.
A particularly severe stimulus is provided by the mutation in
hsdM (F269G) that results in a modification-deficient, restric-
tion-proficient EcoKI complex (Fig. 6a). For this mutant to
survive, despite an unmodified chromosome, restriction alle-
viation must be extraordinarily effective. A more common
stimulus is DNA damage that elicits RecA-dependent repair.
UV irradiation and mutations in dam can cause DSBs (26, 33);
nalidixic acid and mutations in topA are likely to generate
DSBs by stalling replication. Damage by UV light also leads to
lesions in one strand that are repaired postreplicatively (34).
RecA-dependent repair relies on homologous recombination.
If homologous recombination involves two segments of hemi-
methylated DNA, the annealing of unmethylated strands or
DNA synthesis may generate a localized region of unmethyl-
ated DNA. In contrast, both 2-AP and mutD increase the
frequency of base pair transitions (29, 35). Some mutations will
generate new target sequences, all of which will be unmodified.
Our experiments have shown a ClpXP-dependent loss of
HsdR in response to 2-AP. It seems likely that the ClpXP
protease itself degrades HsdR, rather than being necessary to
maintain or activate another protease. The only protease-
deficient mutants found to affect the transmission of the genes
encoding EcoKI were clpX and clpP (10). Our experiments also
show that HsdR is lost only in cells in which HsdR could
produce functional EcoKI. Thus, in the absence of HsdM and
HsdS, wild-type HsdR is not degraded; likewise, in the pres-
ence of HsdM and HsdS, a missense mutation in hsdR prevents
degradation of the nonfunctional polypeptide. The require-
ment for unmodified targets and functional EcoKI might
suggest that DNA breakage initiates the RA response. We
argue that DSBs are not involved in the initiation of RA. One
reason for doubting this idea is our observation that a
recAclp1hsd1 bacterium is no more sensitive to 2-AP than its
rec1 counterpart. This finding is not consistent with the
creation of DSBs in response to 2-AP. Second, we tested
whether active EcoAI, a member of the type IB family of
enzymes is sufficient to induce loss of the HsdR subunit of
EcoKI in response to treatment with 2-AP. It is not, although
it is susceptible to ClpXP-dependent RA. If DSBs are the
signal for RA, those made by EcoAI do not provide a signal
for degradation of the HsdR subunit of EcoKI. Finally, even
in the absence of RecA we readily made strains in which EcoKI
is defective in methyltransferase activity (Fig. 6). Because
DSBs cannot be repaired in a recA2 strain (36), it would appear
that in this hsdR1M(F269G) S1 bacterium DSBs are avoided,
despite the presence of ’600 unmodified targets and the
coding potential for restriction-proficient, modification-
deficient EcoKI. We conclude that ClpXP-dependent degra-
dation of HsdR is able to prevent cutting of the bacterial
chromosome. In the absence of ClpXP, however, even rec1
cells fail to survive because EcoKI cuts their chromosomes.
If DSBs are not the stimulus for RA, why does a missense
mutation in hsdR prevent degradation of HsdR? The amino
acid substitution (A619V) is associated with a defect in the
hydrolysis of ATP and probably, therefore, with the ATP-
dependent translocation of DNA that precedes the generation
of DSBs (18). The missense mutation does not prevent either
the binding of EcoKI to its target sequence or the associated
ATP-dependent conformational change that is a prerequisite
for the restriction pathway (18, 37). Other missense mutations
in HsdR also prevent degradation of HsdR (V.A.D. and
N.E.M., unpublished observations); therefore, it seems prob-
able that the functional defect, rather than the amino acid
substitution per se, determines whether the enzyme is a sub-
strate for ClpXP. We conclude that HsdR is recognized only
after the EcoKI complex has embarked on its restriction
pathway. It remains to be determined what renders the HsdR
FIG. 7. The effect of hsdM (F269G) on the level of HsdR. The
mutation hsdM (F269G) destroys only the modification activity of
EcoKI. The level of HsdR was monitored by Western blots by using
antibody against EcoKI. Lanes 1–6 include extracts of strains. Lanes:
1, NK301 (hsd1); 2, NK386 [an hsdM (F269G) derivative of NK301];
3, an hsd1 derivative of NK386; 4, an hsdR(A619V) derivative of
NK386 (NK388) in which alleles of hsd genes were replaced by using
lhsd phages that included only hsdMS or hsdR, respectively; 5, NM802
(an hsdR deletion strain); and 6, NK352 (an hsdMS deletion strain).
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subunits susceptible to proteolysis. Nevertheless, the present
experiments promote the concept of a remarkably specific
control mechanism, effective only once the relevant restriction
pathway has been initiated, but able to act before any damage
is inflicted on unmodified chromosomal DNA.
The RA response can protect the bacterial chromosome
from restriction in the complete absence of modification, but
the alleviation is not entirely complete when analyzed by
infection with l.0 (EOP 5 1021). These facts raise two new, but
probably related, problems. First, why does phage DNA en-
tering the cell show some susceptibility to restriction whereas
the resident bacterial chromosome does not? Second, why do
unmodified targets on the chromosome, but not those on
incoming phage DNA, stimulate the RA response? At present,
it should be borne in mind that the two substrates differ in their
location and their association with other proteins.
Our current experiments document the disappearance of
HsdR under conditions of RA, and we interpret this as
ClpXP-dependent degradation of HsdR. Initial but unsuccess-
ful attempts to detect degradation in vitro used purified HsdR,
or EcoKI, as substrate. The in vivo experiments indicate that
the substrate is unlikely to be protein alone but, rather, a
functional protein–DNA complex.
The role of ClpXP in the disassembly and degradation of the
Mu transposase already is known to be complex. MuB appar-
ently protects the MuA–DNA complex from recognition by
ClpX and, hence, from disassembly and potential degradation
by the protease activity of ClpP (38). These authors suggested
‘‘that a protein–complex architecture that uses overlapping
sequences for subunit interactions and for targeting a protein
for remodeling or destruction provides a useful design for this
type of regulation.’’ By analogy we would suggest that some
step in the ATP-dependent DNA translocation by EcoKI leads
to the exposure of the target sequence for ClpX.
Our investigation of the relevance of ClpXP to RA has been
confined to the type IA and IB families of R-M systems. There
is evidence for Dam-mediated RA of a type III system (26).
Members of the type IC and ID families are susceptible to RA in
response to 2-AP (unpublished results), but transmission of the
plasmid-borne type IC hsd genes by conjugation is not dependent
on ClpXP (10, 32). Although the assembly pathway of the R2M2S1
complex may provide a lag in the production of the endonuclease
after plasmid transfer (39), it would not prevent the cutting of
unmodified targets created in cells in which functional endonu-
clease is already assembled. It is not known whether RA can
involve other proteases or other mechanisms, but RA is found for
some methylation-dependent restriction systems (24), where
DNA damage would not generate target sequences. RA has not
been detected for any type II system; rather, RA appears to be
characteristic of complex R-M systems.
Our experiments demonstrate that control of the restriction
activity of EcoKI is extraordinarily sensitive. It not only copes with
the acquisition of hsd genes conferring new specificities and the
production of unmodified targets created by repair and mutation,
but clp1 cells also survive a mutation that destroys the modifi-
cation activity of the R-M complex. A similar control system
could permit the efficient phase variation of type I R-M systems,
a phenomenon recently documented for Mycoplasma pulmonis
(40). Molecular mechanisms of the sophisticated interactions that
mediate the proteolytic control remain to be determined.
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